CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17 | -75.4% | 48,633 | -62.9% | 0.00% | -88.9% |
| Q4 2022 | $69 | -99.9% | 131,218 | -30.6% | 0.01% | 0.0% |
| Q3 2022 | $95,000 | -1.0% | 189,175 | +250.5% | 0.01% | +12.5% |
| Q2 2022 | $96,000 | +123.3% | 53,977 | +13.8% | 0.01% | +100.0% |
| Q4 2021 | $43,000 | -64.2% | 47,441 | +63.0% | 0.00% | -63.6% |
| Q3 2021 | $120,000 | -78.9% | 29,103 | +32.3% | 0.01% | -64.5% |
| Q1 2018 | $568,000 | – | 21,997 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |